BiBB receives approval of two patents in Europe for EndoDrill
The cancer diagnostics company BiBBInstruments AB ("BiBB or the "Company") today announces that the European Patent Office (EPO) has finally approved two patent applications for EndoDrill[®]. The patents provide broad protection of the EndoDrill[®] system until 2038 and 2039, respectively.The approvals relate to patent applications EP19780264.8 and EP18199230.6 from patent family 1 and follow previous Intention to Grants from the EPO announced in Q1 2023. The patents protect the EndoDrill[®] product series, the world's first market-cleared electric-driven biopsy instrument for endoscopy.